Global pharmaceuticals industry is facing a crisis over R&D productivity, soaring drug costs, reducing time-to-market and pressure to maintain competitive prices. As a result, global multinationals are seeking novel ways to drive growth, with many opting to increase their reliance on third parties - through licensing, and partnership agreements. In the light of this new trend, the vendor-customer equation has now evolved into strategic partner model.

This is an extract from the Update Newsletter to our report "Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India". The newsletters are sent complimentary with the report.

To purchase the report, click here.